Submitted by Anonymous (not verified) on 22 November 2024 - 13:17
Opinion/decision on a Paediatric investigation plan (PIP): Libtayo, Cemiplimab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0414/2023
Source: